The characterization of transcriptional complexes could allow the identification of target-specific molecules and the development of novel pharmacological repertoires for the therapeutic regulation of the transcription of genes such as PNPT1, whose overexpression is associated with serious diseases like liver cancer. Here, PNPT1 is linked to liver cancer.